The allogeneic human chondrocyte market — donor-derived cartilage cell therapies used to repair cartilage defects in the knee, hip, and other joints as an alternative to harvesting a patient's own cartilage cells — is expanding steadily as an off-the-shelf alternative to the decades-old autologous chondrocyte implantation standard, with the Allogeneic Human Chondrocyte Market valued...
Deutsch
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek